Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.8080
-0.0170 (-2.06%)
At close: Apr 1, 2025, 4:00 PM
0.8061
-0.0019 (-0.24%)
After-hours: Apr 1, 2025, 4:07 PM EDT

Kronos Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-86.08-112.67-133.2-151.08-88.44
Upgrade
Depreciation & Amortization
1.722.142.271.980.84
Upgrade
Other Amortization
----3.89
Upgrade
Asset Writedown & Restructuring Costs
27.633.16--3.57
Upgrade
Loss (Gain) From Sale of Investments
-2.81-5.34-0.5340.33
Upgrade
Stock-Based Compensation
9.2224.9831.1526.213.75
Upgrade
Other Operating Activities
2.783.273.222.5931.7
Upgrade
Change in Accounts Payable
1.52-4.154.03-3.22.81
Upgrade
Change in Unearned Revenue
-11.8513.71---
Upgrade
Change in Other Net Operating Assets
-7.57-3.692.151.583.65
Upgrade
Operating Cash Flow
-65.44-78.58-90.93-117.92-37.91
Upgrade
Capital Expenditures
-0-0.68-0.58-4.26-9.57
Upgrade
Investment in Securities
85.4467.05-31.6567.98-150.67
Upgrade
Investing Cash Flow
85.4466.37-32.2263.72-160.24
Upgrade
Long-Term Debt Issued
----151.28
Upgrade
Long-Term Debt Repaid
----0.01-0.03
Upgrade
Net Debt Issued (Repaid)
----0.01151.24
Upgrade
Issuance of Common Stock
0.250.570.854.47264.37
Upgrade
Financing Cash Flow
0.250.570.854.46415.61
Upgrade
Net Cash Flow
20.25-11.65-122.3-49.74217.47
Upgrade
Free Cash Flow
-65.44-79.26-91.5-122.18-47.48
Upgrade
Free Cash Flow Margin
-664.49%-1260.51%---
Upgrade
Free Cash Flow Per Share
-1.09-1.37-1.63-2.23-2.92
Upgrade
Levered Free Cash Flow
-30.74-43.82-43.3-72.4-35.88
Upgrade
Unlevered Free Cash Flow
-30.74-43.82-43.3-72.4-37.34
Upgrade
Change in Net Working Capital
6.94-2.99-9.561.7-3.91
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q